[go: up one dir, main page]

WO2002002092A3 - Compositions based on aminoacids, suitable for improving muscle performance - Google Patents

Compositions based on aminoacids, suitable for improving muscle performance Download PDF

Info

Publication number
WO2002002092A3
WO2002002092A3 PCT/IB2001/001182 IB0101182W WO0202092A3 WO 2002002092 A3 WO2002002092 A3 WO 2002002092A3 IB 0101182 W IB0101182 W IB 0101182W WO 0202092 A3 WO0202092 A3 WO 0202092A3
Authority
WO
WIPO (PCT)
Prior art keywords
amino acids
active ingredients
compositions based
improving muscle
aminoacids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2001/001182
Other languages
French (fr)
Other versions
WO2002002092A2 (en
Inventor
Francesco Saverio Dioguardi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Professional Dietetics SpA
Original Assignee
Professional Dietetics SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Professional Dietetics SpA filed Critical Professional Dietetics SpA
Priority to EP01940936A priority Critical patent/EP1296668A2/en
Priority to US10/332,237 priority patent/US20030187049A1/en
Priority to AU2001274422A priority patent/AU2001274422A1/en
Publication of WO2002002092A2 publication Critical patent/WO2002002092A2/en
Publication of WO2002002092A3 publication Critical patent/WO2002002092A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Compositions based on amino acids are described, in particular for oral or parenteral use, suitable for improving muscle performances. The compositions according to the invention comprise up to 75% of the branched chain amino acids leucine, isoleucine and valine, as active ingredients. Preferably, the compositions also comprise, as further active ingredients, up to 50% of threonine and lysine. Other essential amino acids are preferably also provided (in particular methionine, phenylalanine, histidine, triphtophan) as well as non essential amino acids (in particular tyrosine and/or cyst(e)ine-i.e. cystine and cyst(e)ine). Other amino acids can be added, provided that their sum is in a percentage being lower than 20% with respect to the other active ingredients, and less than 10% for each single amino acid.
PCT/IB2001/001182 2000-07-04 2001-06-28 Compositions based on aminoacids, suitable for improving muscle performance Ceased WO2002002092A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP01940936A EP1296668A2 (en) 2000-07-04 2001-06-28 Compositions based on aminoacids, suitable for improving muscle performance
US10/332,237 US20030187049A1 (en) 2000-07-04 2001-06-28 Compositions based on aminoacids, suitable for improving muscle performance
AU2001274422A AU2001274422A1 (en) 2000-07-04 2001-06-28 Compositions based on aminoacids, suitable for improving muscle performance

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000TO000675A IT1320783B1 (en) 2000-07-04 2000-07-04 COMPOSITIONS BASED ON AMINO ACIDS, SUITABLE TO IMPROVE MUSCLE PERFORMANCE.
ITTO2000A000675 2000-07-04

Publications (2)

Publication Number Publication Date
WO2002002092A2 WO2002002092A2 (en) 2002-01-10
WO2002002092A3 true WO2002002092A3 (en) 2002-06-20

Family

ID=11457894

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2001/001182 Ceased WO2002002092A2 (en) 2000-07-04 2001-06-28 Compositions based on aminoacids, suitable for improving muscle performance

Country Status (4)

Country Link
EP (1) EP1296668A2 (en)
AU (1) AU2001274422A1 (en)
IT (1) IT1320783B1 (en)
WO (1) WO2002002092A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITTO20010580A1 (en) * 2001-06-15 2002-12-15 Professional Dietetics Srl AMINO ACID BASED COMPOSITIONS FOR IMPROVING THE MYOCARDIC VENTRICULAR FUNCTION IN PATIENTS WITH DIABETES.
GB2394698A (en) 2002-11-01 2004-05-05 Gibbs Tech Ltd Amphibious vehicle wheel transmission arrangement
IT1397023B1 (en) * 2009-11-27 2012-12-20 Professional Dietetics Srl COMPOSITIONS INCLUDING AMINO ACIDS, FOR THE TREATMENT OF CHRONIC OSTRUCTIVE BRONCOPNEUMOPATHY
IT1397446B1 (en) * 2010-01-12 2013-01-10 Professional Dietetics Srl COMPOSITIONS COMPRISING AMINO ACIDS FOR PREVENTION AND / OR TREATMENT OF RENAL DISORDERS.
PL3006027T3 (en) * 2014-10-08 2018-02-28 Professional Dietetics S.P.A. Compositions comprising amino acids for use in the treatment of systemic inflammation state associated to stroke in patients with dysphagia
JOP20190146A1 (en) 2016-12-19 2019-06-18 Axcella Health Inc Amino acid compositions and methods for the treatment of liver diseases
JP7266581B2 (en) 2017-08-14 2023-04-28 アクセラ・ヘルス・インコーポレイテッド Amino acid composition for treatment of liver disease
WO2019246225A1 (en) 2018-06-20 2019-12-26 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
IT202000021664A1 (en) * 2020-09-14 2022-03-14 Iaf Network S P A BALANCED AMINO ACID FORMULATION

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5276018A (en) * 1992-07-17 1994-01-04 Brigham And Women's Hospital Composition comprising amino acids and methods for decreasing muscle breakdown
WO1998026774A1 (en) * 1996-12-16 1998-06-25 Professional Dietetics S.R.L. Compositions based on aminoacids

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5276018A (en) * 1992-07-17 1994-01-04 Brigham And Women's Hospital Composition comprising amino acids and methods for decreasing muscle breakdown
WO1998026774A1 (en) * 1996-12-16 1998-06-25 Professional Dietetics S.R.L. Compositions based on aminoacids

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"Guide National de Préscription des Médicaments", 1994, EDITIONS DU VIDAL, PARIS, XP002185101 *

Also Published As

Publication number Publication date
AU2001274422A1 (en) 2002-01-14
WO2002002092A2 (en) 2002-01-10
EP1296668A2 (en) 2003-04-02
IT1320783B1 (en) 2003-12-10
ITTO20000675A0 (en) 2000-07-04
ITTO20000675A1 (en) 2002-01-04

Similar Documents

Publication Publication Date Title
WO2006029411A3 (en) Mixtures of polypeptides, compositions containing and processes for preparing same, and uses thereof
WO2005034932A3 (en) Amino acid based compositions for the treatment of pathological conditions distinguished by insufficient mitochondrial function
WO2006105112A3 (en) Amino acid-containing composition for preventing or remedying in the skeletal muscle of aged people
CA2242646A1 (en) Amino acid composition
EP1614675A3 (en) Amino acids with affinity for the alpha-2-delta protein
WO2009057775A1 (en) Anti-fatigue agent comprising amino acid composition
AU1142001A (en) Protein hydrolysates
DE60204714D1 (en) PHARMACOLOGICAL FOOD COMPOSITION FOR FOOD SUPPLEMENT AND NUTRITIONAL IMPROVEMENT
CA2445386A1 (en) Hypotensive lipid (prostaglandin derivatives) and timolol compositions and methods of using same
CY1115918T1 (en) COMPOSITIONS BASED ON BRANCHED AMINOXY CHAIN FOR IMPROVING MYCARDIAL CYCLIC FUNCTION IN PATIENTS WITH PATIENTS
WO2002002092A3 (en) Compositions based on aminoacids, suitable for improving muscle performance
WO2001003684A3 (en) Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
WO2002002103A3 (en) Compositions based on aminoacids, suitable for the treatment of heart failure
ATE261723T1 (en) COMPOSITION OF AMINO ACIDS
CA2455776A1 (en) Amino-acid-based compositions, suitable in therapy for the healing and/or mending of wounds and lesions, in particular for application in the ophthalmic field
AU4653301A (en) Anti-freeze proteins, their production and use
WO2002058589A3 (en) Agents and methods for promoting bone growth
JP2004534073A5 (en)
WO2001005383A3 (en) Inhibition of renal uptake of radiomolecules with a combination of lysine and arginine
EP1153609A4 (en) Amino acid-containing albumin preparations
RU94024392A (en) Mineral amino acid concentrate
CA2782169A1 (en) Compositions comprising amino acids for treating chronic obstructive pulmonary disease
AU2003253510A1 (en) Arginine/lysine-enriched peptides
AU3371593A (en) Highly concentrated amino acid solution
EP0506653A1 (en) Amino acid composition

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 10332237

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2001940936

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001940936

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2001940936

Country of ref document: EP